ADMA Biologics ADMA Operating Lease Incremental Borrowing Rate Percent

Operating Lease Incremental Borrowing Rate Percent at other companies

DJT

Trump Media & Technology GroupDJT

8%+0.1pp

MSCIMSCI

4.4%+0.3pp

The Travelers CompaniesTRV

4.1%+0.3pp

American International GroupAIG

3.2%—

Carrier GlobalCARR

4.6%+0.1pp

3MMMM

3.5%0.0pp

Other financials

Income statement

See full

Revenue$114.5M-0.3%

Gross profit$80.8M+32.2%

Operating income$58.3M+67.1%

Net income$45.3M+68.5%

EPS (diluted)$0.19+72.7%

Balance sheet

See full

Cash & equivalents$138.2M+92.9%

Total debt$204.4M+2,055%

Total equity$390.3M+4.5%

Total assets$665.2M+30.3%

Cash flow

See full

Operating cash flow$58.2M+396%

CapEx$2.5M-45.9%

Free cash flow$55.7M+329%

Valuation

See full

Market cap$2.02B-54.5%

Profitability

See full

Gross margin61.3%+8.7pp

Operating margin42.1%+9.0pp

Net margin32.4%-12.6pp

FCF margin21.2%+1.4pp

Returns & leverage

See full

Return on equity43.3%-35.2pp

Debt / equity0.5×+0.5×

Current ratio7×+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept adma:OperatingLeaseIncrementalBorrowingRatePercent.

The official record: ADMA Biologics’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's operating lease incremental borrowing rate percent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ADMA Biologics's operating lease incremental borrowing rate percent?: ADMA Biologics (ADMA) reported operating lease incremental borrowing rate percent of 13% in Q4 2023.
What does operating lease incremental borrowing rate percent mean?: The estimated interest rate the company would pay to borrow funds on a collateralized basis over a similar term to acquire an asset under a lease. This rate is used to discount lease payments and reflects the company's cost of debt for financing operating assets.